Nucleic Acid Based Therapeutics Market Size, Share, Trends, Growth Outlook

Nucleic Acid Based Therapeutics Market is estimated to increase at a growth rate of 18.4% CAGR over the forecast period from 2024 to 2030.

The global Nucleic Acid Based Therapeutics Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Technology (RNA targeted therapeutics, Gene therapies, Epigenetic and microRNA modulating therapies, Genome editing therapies, Others), By Application (Autoimmune Disorders, Infectious Diseases, Genetic Disorders , Cancer, Others), By End-user (Hospitals & Clinics, Academic & Research Institutes, Others).

An introduction to Nucleic Acid Based Therapeutics Market in 2024

The nucleic acid-based therapeutics market is flourishing in 2024, propelled by advancements in gene editing technologies, RNA interference, and antisense oligonucleotides, offering promising treatment modalities for a wide range of diseases including genetic disorders, cancer, and infectious diseases. Nucleic acid-based therapeutics leverage the body's own molecular machinery to target specific genes or gene products, offering the potential for precise and personalized treatment approaches with fewer side effects. With increasing investment in biotechnology research, regulatory approvals, and clinical successes, this market is poised for transformative growth and therapeutic innovation.

Nucleic Acid Based Therapeutics Market Trend: Advancements in Nucleic Acid Therapeutics Delivery Systems

A prominent trend in the Nucleic Acid Based Therapeutics Market is the continuous advancements in nucleic acid therapeutics delivery systems. Innovations in delivery technologies such as lipid nanoparticles, viral vectors, and polymer-based carriers are enhancing the efficiency, specificity, and safety of nucleic acid-based therapies. These advancements enable targeted delivery of nucleic acid drugs to specific tissues or cells, overcoming barriers such as cellular uptake, endosomal escape, and immune response activation. With the development of more sophisticated delivery systems, the efficacy and therapeutic potential of nucleic acid-based therapies continue to improve, driving the growth of the market.

Nucleic Acid Based Therapeutics Market Driver: Growing Understanding of Disease Genetics and Molecular Mechanisms

A significant driver propelling the Nucleic Acid Based Therapeutics Market is the growing understanding of disease genetics and molecular mechanisms. Advances in genomics, transcriptomics, and molecular biology have revealed the underlying genetic and molecular drivers of various diseases, including genetic disorders, cancer, and infectious diseases. Nucleic acid-based therapeutics, such as antisense oligonucleotides, RNA interference (RNAi) molecules, and gene editing tools, offer precise and targeted approaches to modulate gene expression, correct genetic mutations, and interfere with disease pathways. The expanding knowledge of disease biology and the potential of nucleic acid-based therapies drive the demand for innovative therapeutic interventions and fuel market growth.

Market Opportunity Development of RNA-based Therapies for Rare Diseases

An enticing opportunity within the Nucleic Acid Based Therapeutics Market lies in the development of RNA-based therapies for rare diseases. RNA-based therapeutics, including messenger RNA (mRNA) vaccines, small interfering RNA (siRNA), and antisense oligonucleotides, hold promise for treating rare genetic disorders that lack effective treatment options. With advances in RNA delivery technologies and genome editing tools such as CRISPR-Cas9, there's potential to develop RNA-based therapies that target specific genetic mutations or disease-causing genes, providing personalized treatment options for patients with rare diseases. By focusing on rare disease indications and leveraging RNA-based therapeutic platforms, companies can address unmet medical needs, obtain orphan drug designations, and unlock new opportunities for market expansion and revenue growth.

Nucleic Acid Based Therapeutics Market Market Segmentation

By Technology
RNA targeted therapeutics
Gene therapies
Epigenetic and microRNA modulating therapies
Genome editing therapies
Others
By Application
Autoimmune Disorders
Infectious Diseases
Genetic Disorders
Cancer
Others
By End-User
Hospitals & Clinics
Academic & Research Institutes
Others

Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Nucleic Acid Based Therapeutics Market Companies

Alnylam Pharmaceuticals Inc
Arrowhead Pharmaceuticals Inc
Biogen Inc
Ionis Pharmaceuticals Inc
Moderna Inc
Novartis Pharma AG
Sarepta Therapeutics Inc
Silence Therapeutics PLC
Stoke Therapeutics Inc
Wave Life Sciences

Reasons to Buy the Nucleic Acid Based Therapeutics Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Nucleic Acid Based Therapeutics Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Nucleic Acid Based Therapeutics Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Nucleic Acid Based Therapeutics Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Nucleic Acid Based Therapeutics Market Size Outlook, $ Million, 2021 to 2030
3.2 Nucleic Acid Based Therapeutics Market Outlook by Type, $ Million, 2021 to 2030
3.3 Nucleic Acid Based Therapeutics Market Outlook by Product, $ Million, 2021 to 2030
3.4 Nucleic Acid Based Therapeutics Market Outlook by Application, $ Million, 2021 to 2030
3.5 Nucleic Acid Based Therapeutics Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Nucleic Acid Based Therapeutics Industry
4.2 Key Market Trends in Nucleic Acid Based Therapeutics Industry
4.3 Potential Opportunities in Nucleic Acid Based Therapeutics Industry
4.4 Key Challenges in Nucleic Acid Based Therapeutics Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Nucleic Acid Based Therapeutics Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Nucleic Acid Based Therapeutics Market Outlook by Segments
7.1 Nucleic Acid Based Therapeutics Market Outlook by Segments, $ Million, 2021- 2030
By Technology
RNA targeted therapeutics
Gene therapies
Epigenetic and microRNA modulating therapies
Genome editing therapies
Others
By Application
Autoimmune Disorders
Infectious Diseases
Genetic Disorders
Cancer
Others
By End-User
Hospitals & Clinics
Academic & Research Institutes
Others

8 North America Nucleic Acid Based Therapeutics Market Analysis and Outlook To 2030
8.1 Introduction to North America Nucleic Acid Based Therapeutics Markets in 2024
8.2 North America Nucleic Acid Based Therapeutics Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Nucleic Acid Based Therapeutics Market size Outlook by Segments, 2021-2030
By Technology
RNA targeted therapeutics
Gene therapies
Epigenetic and microRNA modulating therapies
Genome editing therapies
Others
By Application
Autoimmune Disorders
Infectious Diseases
Genetic Disorders
Cancer
Others
By End-User
Hospitals & Clinics
Academic & Research Institutes
Others

9 Europe Nucleic Acid Based Therapeutics Market Analysis and Outlook To 2030
9.1 Introduction to Europe Nucleic Acid Based Therapeutics Markets in 2024
9.2 Europe Nucleic Acid Based Therapeutics Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Nucleic Acid Based Therapeutics Market Size Outlook by Segments, 2021-2030
By Technology
RNA targeted therapeutics
Gene therapies
Epigenetic and microRNA modulating therapies
Genome editing therapies
Others
By Application
Autoimmune Disorders
Infectious Diseases
Genetic Disorders
Cancer
Others
By End-User
Hospitals & Clinics
Academic & Research Institutes
Others

10 Asia Pacific Nucleic Acid Based Therapeutics Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Nucleic Acid Based Therapeutics Markets in 2024
10.2 Asia Pacific Nucleic Acid Based Therapeutics Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Nucleic Acid Based Therapeutics Market size Outlook by Segments, 2021-2030
By Technology
RNA targeted therapeutics
Gene therapies
Epigenetic and microRNA modulating therapies
Genome editing therapies
Others
By Application
Autoimmune Disorders
Infectious Diseases
Genetic Disorders
Cancer
Others
By End-User
Hospitals & Clinics
Academic & Research Institutes
Others

11 South America Nucleic Acid Based Therapeutics Market Analysis and Outlook To 2030
11.1 Introduction to South America Nucleic Acid Based Therapeutics Markets in 2024
11.2 South America Nucleic Acid Based Therapeutics Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Nucleic Acid Based Therapeutics Market size Outlook by Segments, 2021-2030
By Technology
RNA targeted therapeutics
Gene therapies
Epigenetic and microRNA modulating therapies
Genome editing therapies
Others
By Application
Autoimmune Disorders
Infectious Diseases
Genetic Disorders
Cancer
Others
By End-User
Hospitals & Clinics
Academic & Research Institutes
Others

12 Middle East and Africa Nucleic Acid Based Therapeutics Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Nucleic Acid Based Therapeutics Markets in 2024
12.2 Middle East and Africa Nucleic Acid Based Therapeutics Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Nucleic Acid Based Therapeutics Market size Outlook by Segments, 2021-2030
By Technology
RNA targeted therapeutics
Gene therapies
Epigenetic and microRNA modulating therapies
Genome editing therapies
Others
By Application
Autoimmune Disorders
Infectious Diseases
Genetic Disorders
Cancer
Others
By End-User
Hospitals & Clinics
Academic & Research Institutes
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Alnylam Pharmaceuticals Inc
Arrowhead Pharmaceuticals Inc
Biogen Inc
Ionis Pharmaceuticals Inc
Moderna Inc
Novartis Pharma AG
Sarepta Therapeutics Inc
Silence Therapeutics PLC
Stoke Therapeutics Inc
Wave Life Sciences
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Technology
RNA targeted therapeutics
Gene therapies
Epigenetic and microRNA modulating therapies
Genome editing therapies
Others
By Application
Autoimmune Disorders
Infectious Diseases
Genetic Disorders
Cancer
Others
By End-User
Hospitals & Clinics
Academic & Research Institutes
Others